Atrás
Rango del Día
$18.61
$19.22
Rango de 52 Semanas
$10.01
$24.33
Volumen
187,677
Promedio 50D / 200D
$20.20
/
$16.40
Cierre Anterior
$18.50
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -13.4 | 0.4 |
| P/B | 4.6 | 2.9 |
| ROE % | -30.8 | 3.7 |
| Net Margin % | -60.0 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Puntos Clave
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -41.58M
PEG of 0.26 suggests growth is underpriced
Capital efficient — spends only 0.86% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)36.09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-30.83%
ROIC-24.66%
Net Margin-59.97%
Op. Margin-65.57%
Seguridad
Debt / Equity
0.14
Current Ratio9.73
Interest Coverage-30.90
Valoración
P/E Ratio
-13.39
P/B Ratio4.60
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36.09% | Revenue Growth (3Y) | 40.33% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 89.06M | Net Income (TTM) | -53.41M |
| ROE | -30.83% | ROA | -27.28% |
| Gross Margin | 87.89% | Operating Margin | -65.57% |
| Net Margin | -59.97% | Free Cash Flow (TTM) | -41.58M |
| ROIC | -24.66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 9.73 |
| Interest Coverage | -30.90 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -13.39 | P/B Ratio | 4.60 |
| P/S Ratio | 8.03 | PEG Ratio | 0.26 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 715.18M | Enterprise Value | 696.98M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 89.06M | 65.44M | 45.23M | 25.92M |
| Net Income | -53.41M | -40.46M | -29.46M | -37.16M |
| EPS (Diluted) | -1.46 | -3.39 | -1.26 | -1.59 |
| Gross Profit | 78.27M | 56.75M | 38.16M | 21.49M |
| Operating Income | -58.40M | -39.71M | -30.04M | -36.02M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 195.80M | 225.41M | 58.92M | 86.46M |
| Total Liabilities | 40.47M | 34.25M | 171.17M | 172.86M |
| Shareholders' Equity | 155.34M | 191.17M | -112.25M | -86.40M |
| Total Debt | 22.28M | 21.96M | 14.20M | 18.22M |
| Cash & Equivalents | 40.48M | 194.37M | 34.50M | 68.24M |
| Current Assets | 186.72M | 217.27M | 51.96M | 79.80M |
| Current Liabilities | 19.19M | 12.99M | 21.60M | 9.86M |